These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31260163)

  • 1. Metabolism and Gut Microbiota in Cancer Immunoediting, CD8/Treg Ratios, Immune Cell Homeostasis, and Cancer (Immuno)Therapy: Concise Review.
    Kareva I
    Stem Cells; 2019 Oct; 37(10):1273-1280. PubMed ID: 31260163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.
    Yu YR; Ho PC
    Clin Exp Immunol; 2019 Aug; 197(2):153-160. PubMed ID: 30873592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From mice to humans: developments in cancer immunoediting.
    Teng MW; Galon J; Fridman WH; Smyth MJ
    J Clin Invest; 2015 Sep; 125(9):3338-46. PubMed ID: 26241053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Immunoediting in the Era of Immuno-oncology.
    Gubin MM; Vesely MD
    Clin Cancer Res; 2022 Sep; 28(18):3917-3928. PubMed ID: 35594163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of gut microbiota on immune cell ferroptosis: A novel insight for immunotherapy against tumor.
    Liu R; Wang J; Liu Y; Gao Y; Yang R
    Cancer Lett; 2024 Aug; 598():217115. PubMed ID: 39025428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunometabolism: A new target for improving cancer immunotherapy.
    Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
    Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Cancer Immunoediting to New Strategies in Cancer Immunotherapy: The Roles of Immune Cells and Mechanics in Oncology.
    Aragon-Sanabria V; Kim GB; Dong C
    Adv Exp Med Biol; 2018; 1092():113-138. PubMed ID: 30368751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of costimulatory and inhibitory receptors in FoxP3
    Toker A; Ohashi PS
    Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance.
    Hibino S; Chikuma S; Kondo T; Ito M; Nakatsukasa H; Omata-Mise S; Yoshimura A
    Cancer Res; 2018 Jun; 78(11):3027-3040. PubMed ID: 29559474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inosine, gut microbiota, and cancer immunometabolism.
    Samami E; Aleebrahim-Dehkordi E; Mohebalizadeh M; Yaribash S; Saghazadeh A; Rezaei N
    Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E1-E8. PubMed ID: 36416582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
    Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
    Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the Microbiome for Pancreatic Cancer Immunotherapy.
    Vitiello GA; Cohen DJ; Miller G
    Trends Cancer; 2019 Nov; 5(11):670-676. PubMed ID: 31735286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunometabolism: new insights and lessons from antigen-directed cellular immune responses.
    Ramalho R; Rao M; Zhang C; Agrati C; Ippolito G; Wang FS; Zumla A; Maeurer M
    Semin Immunopathol; 2020 Jun; 42(3):279-313. PubMed ID: 32519148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Gut Microbiota in Tumor Immunotherapy.
    Wu M; Bai J; Ma C; Wei J; Du X
    J Immunol Res; 2021; 2021():5061570. PubMed ID: 34485534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.
    Andrews MC; Reuben A; Gopalakrishnan V; Wargo JA
    Front Immunol; 2018; 9():946. PubMed ID: 29780391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells.
    Payne KK; Keim RC; Graham L; Idowu MO; Wan W; Wang XY; Toor AA; Bear HD; Manjili MH
    J Leukoc Biol; 2016 Sep; 100(3):625-35. PubMed ID: 26928306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
    Wang H; Franco F; Ho PC
    Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.